Observational studyCurrent oncology (Toronto, Ont.)2025

Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence.

Francisco Javier Muñoz-Carrillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.